Cargando…

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease

Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranger, Kévin, Marchalant, Yannick, Bonnet, Amandine E., Crouzin, Nadine, Carrete, Alex, Paumier, Jean-Michel, Py, Nathalie A., Bernard, Anne, Bauer, Charlotte, Charrat, Eliane, Moschke, Katrin, Seiki, Mothoharu, Vignes, Michel, Lichtenthaler, Stefan F., Checler, Frédéric, Khrestchatisky, Michel, Rivera, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700096/
https://www.ncbi.nlm.nih.gov/pubmed/26202697
http://dx.doi.org/10.1007/s00018-015-1992-1
_version_ 1782408274967003136
author Baranger, Kévin
Marchalant, Yannick
Bonnet, Amandine E.
Crouzin, Nadine
Carrete, Alex
Paumier, Jean-Michel
Py, Nathalie A.
Bernard, Anne
Bauer, Charlotte
Charrat, Eliane
Moschke, Katrin
Seiki, Mothoharu
Vignes, Michel
Lichtenthaler, Stefan F.
Checler, Frédéric
Khrestchatisky, Michel
Rivera, Santiago
author_facet Baranger, Kévin
Marchalant, Yannick
Bonnet, Amandine E.
Crouzin, Nadine
Carrete, Alex
Paumier, Jean-Michel
Py, Nathalie A.
Bernard, Anne
Bauer, Charlotte
Charrat, Eliane
Moschke, Katrin
Seiki, Mothoharu
Vignes, Michel
Lichtenthaler, Stefan F.
Checler, Frédéric
Khrestchatisky, Michel
Rivera, Santiago
author_sort Baranger, Kévin
collection PubMed
description Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examined the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP(−/−) mice. At early stages (4 months) of the pathology, the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP(−/−), compared to 5xFAD mice. Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases. The positive impact of MT5-MMP deficiency was still noticeable at 16 months of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice. MT5-MMP expressed in HEKswe cells colocalized and co-immunoprecipitated with APP and significantly increased the levels of Aβ and C99. MT5-MMP also promoted the release of a soluble APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP(−/−) mice, supporting altogether the idea that MT5-MMP influences APP processing. MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metabolism, whose deficiency alleviates amyloid pathology, neuroinflammation and cognitive decline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00018-015-1992-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4700096
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-47000962016-01-11 MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Baranger, Kévin Marchalant, Yannick Bonnet, Amandine E. Crouzin, Nadine Carrete, Alex Paumier, Jean-Michel Py, Nathalie A. Bernard, Anne Bauer, Charlotte Charrat, Eliane Moschke, Katrin Seiki, Mothoharu Vignes, Michel Lichtenthaler, Stefan F. Checler, Frédéric Khrestchatisky, Michel Rivera, Santiago Cell Mol Life Sci Research Article Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examined the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP(−/−) mice. At early stages (4 months) of the pathology, the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP(−/−), compared to 5xFAD mice. Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases. The positive impact of MT5-MMP deficiency was still noticeable at 16 months of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice. MT5-MMP expressed in HEKswe cells colocalized and co-immunoprecipitated with APP and significantly increased the levels of Aβ and C99. MT5-MMP also promoted the release of a soluble APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP(−/−) mice, supporting altogether the idea that MT5-MMP influences APP processing. MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metabolism, whose deficiency alleviates amyloid pathology, neuroinflammation and cognitive decline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00018-015-1992-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-07-23 2016 /pmc/articles/PMC4700096/ /pubmed/26202697 http://dx.doi.org/10.1007/s00018-015-1992-1 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Baranger, Kévin
Marchalant, Yannick
Bonnet, Amandine E.
Crouzin, Nadine
Carrete, Alex
Paumier, Jean-Michel
Py, Nathalie A.
Bernard, Anne
Bauer, Charlotte
Charrat, Eliane
Moschke, Katrin
Seiki, Mothoharu
Vignes, Michel
Lichtenthaler, Stefan F.
Checler, Frédéric
Khrestchatisky, Michel
Rivera, Santiago
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title_full MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title_fullStr MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title_full_unstemmed MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title_short MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
title_sort mt5-mmp is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700096/
https://www.ncbi.nlm.nih.gov/pubmed/26202697
http://dx.doi.org/10.1007/s00018-015-1992-1
work_keys_str_mv AT barangerkevin mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT marchalantyannick mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT bonnetamandinee mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT crouzinnadine mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT carretealex mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT paumierjeanmichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT pynathaliea mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT bernardanne mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT bauercharlotte mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT charrateliane mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT moschkekatrin mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT seikimothoharu mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT vignesmichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT lichtenthalerstefanf mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT checlerfrederic mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT khrestchatiskymichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease
AT riverasantiago mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease